Figure 2.
Figure 2. Hematopoietic engraftment kinetics. (A) Cumulative incidence of neutrophil engraftment (defined as >0.5 × 109/L for 3 consecutive days). Median time to neutrophil engraftment was 11 days in MRD transplants and 15 days in MUD/MMUD transplants. (B) Cumulative incidence of neutrophil engraftment in the 2 main diagnostic groups. Median time to neutrophil engraftment was 11 days in non-CGD PIDs and 16 days in CGD patients. (C) Cumulative incidence of platelet engraftment (defined as >50 × 109/L for 3 consecutive days). Median time to platelet engraftment was 12 days in MRD transplants and 18 days in MUD/MMUD transplants. (D) Cumulative incidence of platelet engraftment in the 2 main diagnostic groups. Median time to platelet engraftment was 16 days in non-CGD PIDs and 19 days in CGD patients.

Hematopoietic engraftment kinetics. (A) Cumulative incidence of neutrophil engraftment (defined as >0.5 × 109/L for 3 consecutive days). Median time to neutrophil engraftment was 11 days in MRD transplants and 15 days in MUD/MMUD transplants. (B) Cumulative incidence of neutrophil engraftment in the 2 main diagnostic groups. Median time to neutrophil engraftment was 11 days in non-CGD PIDs and 16 days in CGD patients. (C) Cumulative incidence of platelet engraftment (defined as >50 × 109/L for 3 consecutive days). Median time to platelet engraftment was 12 days in MRD transplants and 18 days in MUD/MMUD transplants. (D) Cumulative incidence of platelet engraftment in the 2 main diagnostic groups. Median time to platelet engraftment was 16 days in non-CGD PIDs and 19 days in CGD patients.

Close Modal

or Create an Account

Close Modal
Close Modal